Figure 5

Comparison of overall survival of 12 patients with a blood stage B2 upstaged by flow cytometric Vβ analysis with 27 patients with B2 staged by traditional morphologic assessment (Kaplan–Meier log-rank, P=0.701).
Comparison of overall survival of 12 patients with a blood stage B2 upstaged by flow cytometric Vβ analysis with 27 patients with B2 staged by traditional morphologic assessment (Kaplan–Meier log-rank, P=0.701).